Al Malki, M. M., Nathwani, N., Yang, D., Armenian, S., Dadwal, S., Salman, J., . . . Nakamura, R. (2018). Melphalan-based reduced intensity conditioning is associated with favorable disease control and acceptable toxicities in patients older than 70 with hematologic malignancies undergoing allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant.
Chicago Stili AlıntıAl Malki, Monzr M., et al. "Melphalan-based Reduced Intensity Conditioning Is Associated With Favorable Disease Control and Acceptable Toxicities in Patients Older Than 70 With Hematologic Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation." Biol Blood Marrow Transplant 2018.
MLA AlıntıAl Malki, Monzr M., et al. "Melphalan-based Reduced Intensity Conditioning Is Associated With Favorable Disease Control and Acceptable Toxicities in Patients Older Than 70 With Hematologic Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation." Biol Blood Marrow Transplant 2018.